Both are choline delivery vehicles that actually reach the brain, which cheap choline like lecithin and choline bitartrate mostly fails to do 1. Inside neurons they feed acetylcholine, what your memory and attention systems use. The open question is whether choline supply is actually your bottleneck when you're well-fed and not yet aging. Most adults miss the daily choline target from food 2, and higher dietary choline tracks with better memory 3. That argument runs on eggs and liver first, the pill as backup.
In healthy adults the effect is real but small. Two months on citicoline makes sit-down focus a little easier and holds the second hour when your attention used to drift. It shows up on a stopwatch attention task more than in how you feel 4.
The signal grows when the baseline is lower. In older adults whose memory has started to slip, both compounds held cognitive scores for months while untreated groups declined 5 6. A Cochrane pool of citicoline trials landed on a modest, real memory benefit 7.
The big swings failed. The two largest trials gave 2 grams a day for acute stroke and severe head injury and got nothing on recovery, cognition, or survival 8 9. Citicoline is not a stroke drug.
Alpha-GPC has one narrow gym claim. Taken about an hour before the heaviest set, it lifts peak force on max-effort lifts by roughly 14% 10 11. It does not feel like caffeine and won't replace it.
Doses aren't adventurous, and higher doesn't buy more. The cleanest signals came from the low end. Take with breakfast; late dosing can leave you mildly wired at night. If you have any cardiovascular history, pick citicoline.
Who actually gets something. A healthy young adult gets a small attention lift that lives on a stopwatch more than in felt experience. An older adult whose memory is starting to slip gets the clearer benefit: preserved scores over months. A lifter gets a marginal peak-force bump on the single heaviest set. Everyone else pays $15–30 a month for a difference they won't notice.
The fine print — when to skip it, and what people get wrong
Alpha-GPC tied to a 43% higher stroke rate in a Korean cohort 12; observational and confounded, but with cardiovascular history, default to citicoline. Skip both in pregnancy and breastfeeding. On anticoagulants, clear citicoline with your prescriber.
"Any choline pill does the same job": false, only these two reliably raise brain choline 1. "Citicoline speeds stroke recovery": the two biggest trials say no 8. "Alpha-GPC is a stimulant": it barely feels like anything; the effect is a small force bump.
People expect it to feel like something; it doesn't, and week-one "nothing happened" is usually the true size of the effect in a healthy brain. Pushing to 2 g/day to chase a felt click adds headache and insomnia without benefit. Nothing at week eight means stop, not double.
- 1Conant R, Schauss AG (2004). Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature. Alternative Medicine Review. link
- 2Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (1998). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. link
- 3Poly C et al. (2011). The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort. American Journal of Clinical Nutrition. link
- 4McGlade E et al. (2012). Improved attentional performance following citicoline administration in healthy adult women. Food and Nutrition Sciences. link
- 5Cotroneo AM et al. (2013). Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clinical Interventions in Aging. link
- 6De Jesus Moreno Moreno M (2003). Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clinical Therapeutics. link
- 7Fioravanti M, Yanagi M (2005). Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database of Systematic Reviews. link
- 8Dávalos A et al. (2012). Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). The Lancet. link
- 9Zafonte RD et al. (2012). Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA. link
- 10Bellar D, LeBlanc NR, Campbell B (2015). The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. Journal of the International Society of Sports Nutrition. link
- 11Marcus L et al. (2017). Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. Journal of the International Society of Sports Nutrition. link
- 12Lee G et al. (2021). Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. JAMA Network Open. link
Citicoline and Alpha-GPC
One capsule with breakfast. Zero behavioural change. Pre-lift timing for alpha-GPC adds a small wrinkle on training days.
Citicoline 500 mg/day runs ~$15–25/month; alpha-GPC 600 mg/day ~$15–30/month. Annual cost lands in the $150–350 range — minor but not trivial for an intervention with modest payoff.
Real but small effect on attention and memory. The Cochrane review (Fioravanti 2005) found modest cognitive benefit in older adults with cognitive disorders; McGlade 2012 showed a sustained-attention lift in healthy women; IDEALE (Cotroneo 2013) preserved MMSE in vascular cognitive impairment. Effect sizes are modest and the healthy-young-adult evidence base is thin.
Mechanism is clean (Kennedy-cycle phosphatidylcholine synthesis, acetylcholine precursor) and the Cochrane review found modest cognitive benefit in cognitively-impaired elderly (Fioravanti 2005). But the two largest, best-powered RCTs — ICTUS in acute stroke and COBRIT in TBI — were unambiguously null (Dávalos 2012, Zafonte 2012). Healthy-adult trials are small, sponsored, and use single-task endpoints.
Modest subjective attentional clarity in some users; the McGlade 2012 RCT in healthy women saw a small sustained-attention lift at 250 mg citicoline. Most healthy adults don't notice anything stimulant-like in the first weeks.
Small acute power-output effect for alpha-GPC in trained lifters — Bellar 2015 found ~14% higher peak bench-press force at 600 mg pre-lift; Marcus 2017 saw a small jump-force lift. Not a daily-vitality compound; the score reflects the narrow gym-day effect.